Goldman Sachs cuts Sonic Healthcare stock target to AUD 19.20

Published on 10/15/2026 at 20:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2026 profit reached AUD 621.00 million. Sonic Healthcare stock costs AUD 18.49 on October 15, 2026, up 0.65 percent versus ASX prior close.

Analyst target and annual results

Goldman Sachs lowered its Sonic Healthcare target from AUD 23.70 to AUD 19.20 on October 11, 2026.
Fiscal year 2026 revenue reached AUD 10.90 billion, while underlying net profit came to AUD 621.00 million.
Sonic Healthcare stock stood at AUD 18.49 on October 15, 2026 at 4:10 p.m. AEDT, up 0.65 percent versus the ASX prior close.
Sonic Healthcare's annual meeting is scheduled for November 19, 2026.

Sonic, AU000000SHL7, Illustration mit AI erstellt.

Sonic Healthcare (ISIN AU000000SHL7) was downgraded by Goldman Sachs to Neutral from Buy, with its price target cut from AUD 23.70 to AUD 19.20 on October 11, 2026. The revised target stands 3.84 percent above the AUD 18.49 stock price. Sonic Healthcare stock stood at AUD 18.49 on October 15, 2026 at 4:10 p.m. AEDT, up 0.65 percent versus the ASX prior close.

Target cut highlights funding risk

According to Business Insider, Goldman Sachs cited rising debt costs and funding risks in its October 11, 2026 downgrade. The target reduction of AUD 4.50 equals 18.99 percent from the previous AUD 23.70 level.

Fiscal year results set the base

Sonic Healthcare reported fiscal year 2026 revenue of AUD 10.90 billion, underlying EBITDA of AUD 1.93 billion and underlying net profit of AUD 621.00 million, according to the company's Sonic Healthcare investor materials. Revenue increased 13.00 percent from fiscal year 2025, giving the target-cut debate a measurable earnings base.

Price position and November date

The ASX session showed an open of AUD 18.55, a high of AUD 18.59, a low of AUD 18.26 and volume of 1,931,972 shares on October 15, 2026. The 52-week range was AUD 18.11 to AUD 24.27, placing the stock 23.82 percent below its high and 2.10 percent above its low. Volume was 59.47 percent below the average of 2,950,453 shares.

The company had a market capitalization of AUD 9.1 billion, a P/E ratio of 15.03 and a dividend yield of 6.00 percent on October 15, 2026. Simply Wall St listed the next annual meeting for November 19, 2026.

Comparison with peers

Sonic Healthcare (ASX, AUD): plus 0.65 percent, P/E 15.03, market capitalization AUD 9.1 billion
Quest Diagnostics (NYSE, USD): plus 1.91 percent, P/E 25.23, market capitalization USD 26.3 billion
Labcorp (NYSE, USD): plus 1.76 percent, P/E 26.69, market capitalization USD 26.2 billion

Stock position in Australia

Sonic Healthcare's AUD 18.49 price leaves the stock below the Goldman Sachs target while its fiscal year 2026 revenue growth provides a counterweight to the funding concerns cited in the downgrade. The November 19, 2026 annual meeting is the next dated corporate milestone.

The latest home-market price stood at AUD 18.49 on the ASX on October 15, 2026 at 4:10 p.m. AEDT, up 0.65 percent versus the ASX prior close.